Biblio
Export 957 results:
Author Title [ Type
Filters: First Letter Of Last Name is F [Clear All Filters]
“Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 55, no. 1, pp. 199-217, 2017.
, “Neuroprotective Effects of Ginsenoside Rf on Amyloid-β-Induced Neurotoxicity in vitro and in vivo.”, J Alzheimers Dis, vol. 64, no. 1, pp. 309-322, 2018.
, “Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-β Peptide Toxicity.”, J Alzheimers Dis, vol. 94, no. s1, pp. S97-S108, 2023.
, “Neuropsychiatric and Cognitive Subtypes among Community-Dwelling Older Persons and the Association with DSM-5 Mild Neurocognitive Disorder: Latent Class Analysis.”, J Alzheimers Dis, vol. 62, no. 2, pp. 675-686, 2018.
, “Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.”, J Alzheimers Dis, vol. 58, no. 3, pp. 675-680, 2017.
, “New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1317-1337, 2020.
, “New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S51-S63, 2021.
, “New Gold in Them Thar Hills: Testing a Novel Supply Route for Plant-Derived Galanthamine.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1321-1325, 2017.
, “Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
, “Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
, “Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
, “No Effects of Black Tea on Cognitive Decline Among Older US Men: A Prospective Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 99-105, 2018.
, “No Effects of Black Tea on Cognitive Decline Among Older US Men: A Prospective Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 99-105, 2018.
, “No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 85-99, 2017.
, “Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.”, J Alzheimers Dis, vol. 54, no. 2, pp. 717-21, 2016.
, “Non-Pharmacological Interventions for Feeding and Eating Disorders in Persons with Dementia: Systematic Review and Evidence Summary.”, J Alzheimers Dis, vol. 94, no. 1, pp. 67-88, 2023.
, “Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.”, J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.
, “Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1437-1451, 2018.
, “Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
, “Normal Pressure Hydrocephalus in Down Syndrome: The Report of Two Cases.”, J Alzheimers Dis, vol. 77, no. 3, pp. 979-984, 2020.
, “Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1097-1111, 2017.
, “Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1683-1689, 2018.
, “Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 707-21, 2016.
, “A Novel Small Molecule Modulator of Amyloid Pathology.”, J Alzheimers Dis, vol. 53, no. 1, pp. 273-87, 2016.
, “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
,